Cargando…

Expression and prognostic value of transcription factor PROX1 in colorectal cancer

BACKGROUND: PROX1 is a specific target of the β-catenin/TCF pathway in the intestinal epithelium. It acts as a regulator of progression from a benign to a highly dysplastic phenotype in colorectal tumours. However, the clinical significance of PROX1 expression is not known. METHODS: We studied the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skog, M, Bono, P, Lundin, M, Lundin, J, Louhimo, J, Linder, N, Petrova, T V, Andersson, L C, Joensuu, H, Alitalo, K, Haglund, C H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241535/ https://www.ncbi.nlm.nih.gov/pubmed/21970873 http://dx.doi.org/10.1038/bjc.2011.297

Ejemplares similares

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
por: Böckelman, C, et al.
Publicado: (2011)

PROX1 is a predictor of survival for gliomas WHO grade II
por: Elsir, T, et al.
Publicado: (2011)

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
por: Häyry, V, et al.
Publicado: (2010)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
por: Leitch, E F, et al.
Publicado: (2007)

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
por: Souglakos, J, et al.
Publicado: (2009)

The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
por: Xing, X, et al.
Publicado: (2013)

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
por: Lalmahomed, Z S, et al.
Publicado: (2015)

Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011)

Lack of MMP-9 expression is a marker for poor prognosis in Dukes’ B colorectal cancer
por: Koskensalo, Selja, et al.
Publicado: (2012)

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
por: Eberhard, J, et al.
Publicado: (2012)

PROX1 is a transcriptional regulator of MMP14
por: Gramolelli, Silvia, et al.
Publicado: (2018)

Prognostic value of increase in transcript levels of Tp73 ΔEx2-3 isoforms in low-grade glioma patients
por: Wager, M, et al.
Publicado: (2006)

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
por: Öhlund, D, et al.
Publicado: (2009)

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer
por: Chen, Z-Y, et al.
Publicado: (2015)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
por: Kinoshita, A, et al.
Publicado: (2012)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer
por: Meseure, Didier, et al.
Publicado: (2016)

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2016)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma
por: Zhang, J-B, et al.
Publicado: (2013)

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
por: Leung, W K, et al.
Publicado: (2005)

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients
por: van Nes, J G H, et al.
Publicado: (2009)

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer
por: Hector, S, et al.
Publicado: (2012)

The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
por: Oladipo, O, et al.
Publicado: (2011)

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location
por: Bae, J M, et al.
Publicado: (2013)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma
por: Gordziel, C, et al.
Publicado: (2013)

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
por: de Graeff, P, et al.
Publicado: (2008)

Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value
por: Lomnytska, M I, et al.
Publicado: (2011)

Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
por: Grelier, G, et al.
Publicado: (2009)

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer
por: Andersen, C L, et al.
Publicado: (2009)

ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients
por: Lu, J, et al.
Publicado: (2013)

Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma
por: Kontos, C K, et al.
Publicado: (2010)

Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer
por: Baba, Y, et al.
Publicado: (2010)

KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis
por: Deschoolmeester, V, et al.
Publicado: (2010)

Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer
por: Eisenach, P A, et al.
Publicado: (2013)

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
por: Yokota, T, et al.
Publicado: (2011)

MiR-320e is a novel prognostic biomarker in colorectal cancer
por: Perez-Carbonell, L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3vrin88nsqfbjcj249tv23fn6q